Boehringer Ingelheim opens new ADC facility in Basel, Switzerland
The new 1,826m2 facility with laboratory and office space represents a CHF27m ($31.5m) investment in ADC research and development to advance cancer treatment
Astellas, JFCR partner to drive translational oncology development
Novartis secures FDA accelerated approval for Vanrafia for IgAN
Atsena secures $150m Series C funding to advance gene therapy
Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease
Eton Pharmaceuticals out-licenses Increlex global rights to Esteve
Analysis
View More
Risks
View MoreSocietal polarisation and its impact on the pharmaceutical industry
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry